Venus Remedies Limited (NSE:VENUSREM)
473.75
-9.65 (-2.00%)
Aug 14, 2025, 3:14 PM IST
Venus Remedies Employees
Venus Remedies had 1,298 employees as of March 31, 2025. The number of employees increased by 111 or 9.35% compared to the previous year.
Employees
1,298
Change (1Y)
111
Growth (1Y)
9.35%
Revenue / Employee
5.17M INR
Profits / Employee
413.67K INR
Market Cap
6.31B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1,298 | 111 | 9.35% |
Mar 31, 2024 | 1,187 | 189 | 18.94% |
Mar 31, 2023 | 998 | 56 | 5.94% |
Mar 31, 2022 | 942 | 105 | 12.54% |
Mar 31, 2021 | 837 | -72 | -7.92% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Aurobindo Pharma | 26,015 |
Venus Remedies News
- 3 months ago - Venus Remedies renews GMP certification from Ukraine’s SMDC for Baddi facility - Business Upturn
- 4 months ago - Venus Remedies shares jump 11% after US FDA grants QIDP status to novel antibiotic VRP-034 - Business Upturn
- 4 months ago - Venus Remedies gets US FDA grants QIDP status to novel polymyxin B formulation VRP-034 - Business Upturn
- 6 months ago - Venus Remedies secures exclusive rights for MET-X clinical development in India - Business Upturn
- 7 months ago - Venus Remedies shares surge 10% after EU GMP Certification renewal - Business Upturn
- 7 months ago - Venus Remedies successfully renews EU GMP certification, reinforcing its European market presence - Business Upturn
- 8 months ago - Venus Remedies stock jumps 4% after receiving GMP certification for Antibiotic facility - Business Upturn
- 8 months ago - Venus Remedies shares surge 6% on Pemetrexed marketing authorization in Philippines - Business Upturn